Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
The latest update is out from Teva ( (IL:TEVA) ).
Teva Pharmaceutical Industries Ltd reported a change in the holdings of one of its officers. This announcement may impact perceptions of the company’s governance and management structure among stakeholders, influencing market confidence and potentially affecting the company’s stock performance.
More about Teva
Teva Pharmaceutical Industries Ltd is a global leader in the pharmaceutical industry, primarily focusing on generic medicines, over-the-counter products, and active pharmaceutical ingredients. The company operates worldwide, with a significant presence in the U.S. market.
YTD Price Performance: -25.19%
Average Trading Volume: 1,279,233
Current Market Cap: ILS67.43B
See more insights into TEVA stock on TipRanks’ Stock Analysis page.